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Congenital Zika syndrome (CZS) causes early brain development impairment by affecting
neural progenitor cells (NPCs). Here, we analyze NPCs from three pairs of dizygotic twins
discordant for CZS. We compare by RNA-Seq the NPCs derived from CZS-affected and CZS-
unaffected twins. Prior to Zika virus (ZIKV) infection the NPCs from CZS babies show a
significantly different gene expression signature of mTOR and Wnt pathway regulators, key
to a neurodevelopmental program. Following ZIKV in vitro infection, cells from affected
individuals have significantly higher ZIKV replication and reduced cell growth. Whole-exome
analysis in 18 affected CZS babies as compared to 5 unaffected twins and 609 controls
excludes a monogenic model to explain resistance or increased susceptibility to CZS
development. Overall, our results indicate that CZS is not a stochastic event and depends on
NPC intrinsic susceptibility, possibly related to oligogenic and/or epigenetic mechanisms.
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Zika virus (ZIKV) is a flavivirus that has been associatedwith severe brain abnormalities in newborns1–6. Neuro-developmental dysfunctions of congenital Zika syndrome
(CZS) was shown to be caused by impairments in neural pro-
genitor cell (NPC) growth and survival7, 8. CZS, characterized by
microcephaly and other abnormalities (visual defects, hearing
impairment, skeletal deformities, and epilepsy), occurs in 6–12%
of cases of pregnant women infected by ZIKV4–6. These obser-
vations suggest that ZIKV infection during pregnancy is not
deterministic for CZS phenotype and other susceptibility factors
might be involved. In a previous study, McGrath et al.9 demon-
strated that NPCs from different individuals could respond dif-
ferently under ZIKV infection. This was observed by differential
modulation of intracellular signaling pathways, especially related
to innate immunity, cell cycling, and mammalian target of
rapamycin (mTOR) signaling.
Discordant twins represent a good case–control sample to test
for the genetic contribution determining the fetuses’ outcome of
gestational infection. To the best of our knowledge, no other study
has compared the in vitro NPC expression profile or outcome of
ZIKV infection in human induced pluripotent stem cell (hiPSC)-
derived NPCs from discordant twins for CZS in the same
experimental conditions. Here we show that ZIKV replicates sig-
nificantly more in hiPSC-derived NPCs from affected (CZS) babies
than in the non-affected counterparts. In addition, transcriptome
profiling revealed a different pattern in NPCs from CZS-affected as
compared to CZS-non-affected individuals highlighting the role of
Wnt and mTOR signaling in modulating ZIKV infection outcome.
Results
Subject and samples. A total of nine pairs of Brazilian twins
exposed to ZIKV during pregnancy were identified: seven dizy-
gotic (DZ) and two monozygotic (MZ). The two MZ twins were
both affected (concordant), while among DZ twins, six were
discordant (one affected and one healthy) and only one was
concordant. Despite the relative small sample size, the rate of
discordance among DZ twins and the higher concordance in MZ
than DZ twins could suggest the existence of susceptibility factors
increasing the risk for CZS. We obtained saliva samples from
eight pairs of twins for DNA exome sequencing: two MZ con-
cordant pairs of twins (#10789 and #10835) and six DZ pairs of
twins, one concordant (#11113) and five discordant (#10608,
#10658, #10691, #10763, and #10788). In addition, DNA samples
from 10 unrelated CZS babies were included in this analysis.
Furthermore, we obtained blood from three of the pairs of DZ
discordant twins for generation of hiPSC-derived NPCs (#10608,
#10763, and #10788) (Fig. 1a). All patients’ clinical information is
detailed in Supplementary Data 1.
Whole-exome sequencing analysis. We first analyzed variants in
genes related to Mendelian inherited microcephaly or syndromes
associated with microcephaly (Supplementary Data 2). We did not
identify any pathogenic or probably pathogenic variant in such
genes. A larger number of rare variants (minor allele frequency
<0.01) in eight genes (DEPDC5, GPR108, MICAL3, OR12D2,
OR4K5, PHF2, SLC6A18, and TTC16) was found in affected as
compared to normal babies or control aged population. However,
these differences did not achieve statistical significance (p> 0.05)
after Bonferroni correction. The statistical power was sufficient to
exclude monogenic dominant inheritance (99.57%), whereas
recessive (31.07%) or multifactorial inheritances could not be
excluded as responsible for an increased CZS susceptibility.
Generation and characterization of hiPSCs. Erythroblasts from
three pairs of DZ twins (non-affected: #10608-4, #10763-4, and
#10788-4; affected: #10608-1, #10763-1, and #10788-1) were
reprogrammed towards hiPSCs. All hiPSC lines expressed mar-
kers of pluripotency including TRA-1-60 and OCT4 as demon-
strated by immunofluorescence staining (Fig. 1b, c). Cell lines
were screened with two Multiplex Ligation-dependent Probe
Amplification (MLPA) Kits (P036 and P070, MRC-Holland,
Amsterdam, The Netherlands) for subtelomeric imbalances and
no chromosomal abnormalities were observed (Fig. 1d). Quan-
titative analysis (real-time quantitative PCR (RT-qPCR))
demonstrated expression in the generated hiPSCs of selected
endogenous pluripotent transcription factors including NANOG
and OCT4 (Fig. 1e, f).
Computed tomography. Computed tomography scan (CT scan)
from two pairs of twins out of the three DZ discordant pairs
(#10608 and #10763 twins) revealed typical abnormalities asso-
ciated with CZS in the affected babies, while non-affected cor-
respondent siblings have no visible alterations (Fig. 1g, sub-panels
a′, b′, e′, f′). Main findings observed in CT scan of affected
individuals were brain calcifications, which were mostly puncti-
form (Fig. 1g, sub-panels d′, h′). Microcephaly and malformations
of cortical development can be seen at Fig. 1g, sub-panels c′, g′ as
well as at Fig. 1i. Other findings were ventriculomegaly (Fig. 1g,
sub-panels d′, h′, Fig. 1h) and cortical gyrus simplification.
Infection with ZIKVBR of NPCs from discordant twins. Firstly,
hiPSC-derived NPCs from three pairs of DZ discordant twins
(non-affected: #10608-4, #10763-4, and #10788-4; affected:
#10608-1, #10763-1, and #10788-1) were characterized to confirm
their differentiation in vitro, using our group’s established pro-
tocol for NPC differentiation10. Under these conditions, we found
that all hiPSC-derived NPC lines robustly and homogeneously
express Musashi-1 and Nestin (Fig. 2a–c). Subsequently, we
infected hiPSC-derived NPCs with a Brazilian ZIKV (ZIKVBR)
strain using low multiplicity of infection (MOI) (0.01 and 0.1)
(Fig. 2d). A marked reduction of growth was observed in the
CZS-affected twins’ NPCs at 96 h post infection (hpi) (MOI 0.01,
p< 0.01; MOI 0.1, p< 0.05; two-way analysis of variance
(ANOVA) with Bonferroni post hoc analysis) in monolayer
culture (Fig. 2f, g, Supplementary Fig. 1) and no differences were
observed at mock conditions among affected and non-affected
samples (Fig. 2e). The differences were also confirmed in neu-
rospheres– three-dimensional (3D) cultures (Fig. 2h) with
reduction of diameter at 24 hpi (MOI 0.1; p value = 0.0045; Stu-
dent’s t test) (Fig. 2j) and 96 hpi (MOI 0.01; p value = 0.0116;
Student’s t test) (Fig. 2i).
ZIKV infection analysis. Next, we investigated the viral load by
measuring ZIKVBR copy numbers in NPCs’ culture supernatants
and plaque-forming units (PFU) after 48 and 96 hpi. Viral copy
number represents total viral genome sequences in supernatant
while PFU represents only infective viral particles. Using MOI
0.1, the CZS-affected twins’ NPCs produce significantly more
viral copies/μL at 96 hpi (p value = 0.0013, one-way ANOVA with
Tukey’s post hoc analysis) (Fig. 3a, b, Supplementary Fig. 2).
PFU/mL quantification in culture supernatant was significantly
higher in the affected twins’ NPCs after 96 hpi (MOI 0.01, p value
= 0.0024; MOI 0.1, p< 0.0001, one-way ANOVA with Tukey’s
post hoc analysis) (Fig. 3c, d, h and Supplementary Fig. 2).
Confocal analysis shows significantly higher mean fluorescence
intensity (MFI) of ZIKV staining in affected as compared to non-
affected subjects’ cells (Fig. 3e, f) at 96 hpi (MOI 0.1, p value<
0.001, Student’s t test) (Fig. 3g). These results demonstrate that
NPCs from CZS-affected twins are significantly more susceptible
to ZIKV infection.
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RNA-Seq analysis. RNA sequencing (RNA-Seq) analysis of DZ
twins-derived NPCs prior to ZIKV infection showed 64 differ-
entially expressed genes (DEGs) (p< 0.001, edgeR exact test,
Supplementary Fig. 3a and Supplementary Data 3) when the
NPCs from the affected and non-affected groups were compared.
The gene with the most significant (p value = 1.45E−07, corrected
p value = 0.0058, edgeR exact test, Supplementary Data 3) dif-
ference in expression is DDIT4L, which is an inhibitor of mTOR
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Fig. 1 Experiment design and hiPSC characterization. a Schematic: generation of neural progenitor cells (NPCs) from discordant twins’ hiPSCs following
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(calcifications, ventriculomegaly, and cortical gyrus simplification). Scale bar, 3 cm. h Ventricular area analysis (cm2) (n= 4, two pairs of discordant twins).
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signaling. DDIT4L showed an average 12.6-fold lower mRNA
level in the NPCs from affected twins compared with non-
affected (Fig. 4a and Supplementary Data 3). In addition, we
found a significant (p value< 0.0001, cumulative hypergeometric
distribution) enrichment of five different Gene Ontology (GO)
terms among the 64 DEGs detected in the RNA-Seq experiment
(Fig. 4b). The top most significantly enriched GO is “regionali-
zation,” which includes the related GO cluster members “pattern
specification process,” “anterior/posterior pattern specification,”
“embryonic morphogenesis,” and “embryo development”
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(Supplementary Data 4). Among the DEGs belonging to the
regionalization GO term are FOXG1 and LHX2, which were
down-regulated in affected twins compared with non-affected.
Noteworthy, FOXG1 has been linked to a wide range of
congenital brain disorders11 and disrupting mutations of one
allele of FOXG1 results in the core FOXG1syndrome phenotype,
which includes postnatal microcephaly and severe intellectual
disability12. LHX2 is an early neural marker that regulates neural
differentiation by attenuating the Wnt signaling13. Here we found
that LHX2 mRNA expression was on average 9.6-fold decreased
in the CZS-affected twins’ NPCs compared with non-affected,
which is consistent with the observed increase in expression in
the NPCs from CZS-affected twins of genes related to Wnt
signaling such as EGR2, SFRP2, and WNT7A (Fig. 4a, Supple-
mentary Fig. 3a). The patterns of change in gene expression
between CZS-affected and CZS-non-affected twins for all six
genes were confirmed by RT-qPCR in the twins’ NPC samples, as
seen by a Pearson's correlation r2 = 0.98 between the fold-changes
(FCs) measured by RNA-Seq and RT-qPCR (Supplementary
Fig. 3b). Interestingly, no difference in the levels of expression of
the six genes was observed between the hiPSCs of affected and
non-affected twins from which the NPCs were originated
(Supplementary Fig. 3c), indicating that the differences in
expression appear after differentiation. It should be noted that
the above genes also belong to the “central nervous system
development”-enriched GO term (Fig. 4b, see Supplementary
Data 4), and members of the enriched GO clusters related to the
64 DEGs exhibit extensive interactions among them as shown in
Fig. 4c.
mTOR pathway analysis. We performed a Cell Signaling Mul-
tiplex Assay (Millipore, Billerica, MA) to test for the activity of
proteins in the mTOR signaling pathway. NPCs from the CZS-
affected group showed increased activity of TSC2 (p value =
0.0056, Student’s t test) (Fig. 4d). However, other proteins
involved in mTOR pathway regulation did not show difference
between the two groups (Supplementary Fig. 4). To further test
for the role of mTOR signaling in ZIKV infection of NPCs, we
used an inhibitor and an activator of the pathway. After infection,
cells were treated for 96 h with either 200 nM rapamycin, an
mTOR inhibitor, or 100 nM bafilomycin, an indirect mTOR
signaling inductor. Bafilomycin completely inhibited viral release
while rapamycin increased viral release in non-affected as well as
affected twins’ NPCs (Fig. 4e). However, non-affected twins’
NPCs treated with rapamycin showed a similar PFU/mL to that
observed in non-treated cells from the affected twins (Fig. 4e)
supporting that mTOR individual response is an important factor
for successful ZIKV infection.
Discussion
We were able to study pairs of twins exposed to ZIKV infection
during pregnancy, in which at least one of the babies was born
with CZS. This is a rare and unique cohort to test whether the
host genetic background plays any role in determining CZS
outcome. Altogether, five discordant and DZ pairs of twins plus
three concordant (one DZ and two MZ) were clinically evaluated
and had samples collected. Such proportion of affected vs. non-
affected twins led us to suggest a genetic basis for CZS suscept-
ibility. No rare potentially pathogenic variant was assigned in our
cohort that could explain susceptibility to CZS, allowing us to
exclude monogenic dominant inheritance but not recessive or
multifactorial inheritance, due to our relatively limited sample
size.
NPCs from affected and non-affected groups had similar
growth patterns before ZIKVBR in vitro infection (Fig. 2e). This
may suggest that affected babies would not develop microcephaly
if not exposed to ZIKV during mothers’ pregnancy. After ZIKVBR
infection, NPCs from affected babies showed growth reduction
and higher viral replication when compared to cells from non-
affected babies.
Therefore, we decided to use RNA-Seq to look for intrinsic
differences in NPC gene expression between the two groups,
which could be associated with such differential susceptibility to
ZIKVBR. NPCs from non-affected and CZS-affected twins
showed a significantly differential gene expression signature: we
found a total of 64 significant DEGs when comparing the NPCs
from the three non-affected twins with the three affected ones
(Supplementary Data 3). These DEGs belong to five significantly
enriched GO terms, all related to regionalization and develop-
ment (Fig. 4b and Supplementary Data 4). In mammalian
development, neurogenesis can be drastically affected by varia-
tions in cell proliferation and/or unbalanced neural stem cell
differentiation and such interferences can cause microcephaly or
megalencephaly14. For this reason, in neural stem and progenitor
cells, complex and tightly coordinated gene expression programs
operate, which control cell cycle and cell growth. Therefore,
variants in regulatory regions can deregulate such processes as
well as trigger different epigenetic responses. Epigenetic effects
involving DNA methylation and histone modifications give rise
to differences in gene expression during development, and epi-
genetic mechanisms seem to allow an organism to respond to the
environment through changes in gene expression15.
The gene with the most significant difference in the tran-
scriptome analysis was DDIT4L, which is an inhibitor of mTOR
signaling; DDIT4L showed an average 12.6-fold lower mRNA
level in the NPCs from affected twins compared with non-
affected twins. The literature shows that inhibition of mTORC1
in late corticogenesis16 or hyper-stimulation in early corticogen-
esis in mice causes microcephaly, among other neurological
features10, 17. Dengue and Chikungunya viruses are known to
induce mTORC1 inhibition utilizing a non-canonical pathway to
promote cap-dependent viral RNA translation18–20. Non-
structural proteins (NS4A and NS4B) of ZIKV have been
shown to also inhibit mTOR pathway21. McGrath et al.9 observed
two distinct NPC response patterns to ZIKV infection, the
interferon and the mTOR pathways. Here we show that only
TSC2 activity was significantly higher in affected individuals
(Fig. 4d) and that mTOR activity modulation by rapamycin and
bafilomycin directly modulates ZIKV replication (Fig. 4e).
Fig. 2 NPC characterization and ZIKVBR infection in DZ-D cells (see also Supplementary Fig. 1). a, b NPCs were stained with isotype IgG APC-A and isotype
IgG FITC-A (a) and Nestin APC-A and Musashi-1 FITC-A (b) and were analyzed by flow cytometry to confirm (or show) population homogeneity for neural
progenitor markers. c Nestin staining by immunofluorescence. Scale bar (SB), 20 μm d Representative phase-contrast micrograph of infected NPCs
(#10608 twins). SB, 100 μm. e Analysis of cell number of Mock-infected NPCs from non-affected and CZS-affected twins (n= 3 technical replicates; mean
± SEM). f, g MOI 0.01 and 0.1 infected NPCs from non-affected (#10608-4, #10763-4, and #10788-4) (f) and CZS-affected (#10608-1, #10763-1, and
#10788-1) (g) twins in monolayer cultures at 24, 48, 72, and 96 hpi (n= 3 technical replicates; mean± SEM; *p< 0.05, **p< 0.01; two-way ANOVA with
Bonferroni post hoc analysis). h Representative images of neurospheres infected with ZIKVBR (#10608 twins, n= 2 technical replicates). SB, 400 μm. i, j
Normalized diameter of neurospheres at 24 and 96 hpi with MOI 0.01 (i) or MOI 0.1 (j); #10608, #10763 and #10788 twins; n≅ 15 technical replicates;
mean± SEM; *p< 0.05, **p< 0.01 Student’s t test
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#10763, and #10788 twins. *p< 0.05, **p< 0.01, and ***p< 0.001 one-way ANOVA with Tukey’s post hoc analysis. c, d Zika PFU/mL in NPCs
supernatant (c) MOI= 0.01 and (d) MOI= 0.1; #10608, #10763, and #10788 twins; mean± SEM; **p< 0.01, ***p< 0.001; one-way ANOVA with Tukey’s
post hoc analysis. e, f Zika staining in non-affected (e) and affected (f) twins at an MOI of 0.1 at 96 hpi; #10608, #10763, and #10788 twins. Scale bar=
20 µm. g MFI quantification at 96 hpi (MOI= 0.1; n≅ 20 technical replicates per group; mean± SEM; ***p< 0.001; Student’s t test). h Representation of a
well stained with ZIKV collected from #10608 NPC supernatant at an MOI of 0.1 at 96 hpi
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Although the mechanistic principle of mTOR and Wnt signaling
in neurodevelopment and response to flavivirus infection is well
established, we suggest that host molecular innate control of such
pathways could significantly impact CZS outcome explaining
twins’ discordance.
Taken together, these data show that NPCs derived from non-
affected and CZS-affected twins have significantly different gene
expression signatures of neural development genes and it may
contribute to the different susceptibilities to ZIKVBR infection. In
short, we compared the impact of ZIKVBR infection in NPCs
from three pairs of DZ discordant twins for CZS, demonstrating a
highly increased susceptibility to the pathological effects of
ZIKVBR infection in the affected as compared to the non-affected
group. We could not identify a major locus associated with this
condition suggesting that CZS may be a multifactorial disorder.
Based on our gene expression analyses, we suggest that host
variants in regulatory regions leading to different epigenetic
responses may be a key parameter to predict the success of
ZIKVBR infection in fetuses’ NPCs. Moreover, confirming the
influence of the host genome in CZS predisposition sheds light
into ZIKVBR molecular pathology and opens a path for drug
development targeting specific core pathways to possibly inhibit
viral replication and/or ameliorate cellular pathology.
Methods
Human subjects. Twins from six Brazilian states (Paraíba, Pernambuco, Sergipe,
Bahia, Minas Gerais, and São Paulo) in which at least one was affected by CZS were
selected for this study. Five pairs of DZ-D (dichorionic and diamniotic), one pair of
DZ concordant and two pairs of MZ concordant twins for microcephaly were
examined in this cohort. Zygosity was confirmed by whole-exome sequencing
(WES) and by microsatellite analysis (Supplementary Table 1). In addition, we
collected saliva samples from 10 unrelated CZS babies (#10720-1, #10725-1,
#10727-1, #10729-1, #10739-1, #10661-1, #10693-1, #10701-1, #10741-1, and
#10747-1) for WES. All babies were born from mothers negative for previous
STORCH infections and affected babies’ head circumference were three standard
deviations (SD) below the mean for the given age, sex, and gestation stage at
birth22. Among the DZ-D twins selected in this study, we were able to collect and
isolate peripheral blood mononuclear cell from three pairs only (#10608, #10763,
and #10788). Clinical data from the babies and their respective mothers are detailed
in Supplementary Data 1. The diagnosis of microcephaly due to ZIKV infection
(CZS) in most of all affected subjects selected for this cohort was confirmed by
either neuroimaging (Fig. 1g and Supplementary Data 1), serology, or by the
mother reporting ZIKV infection symptoms during pregnancy. All babies had
saliva samples collected using OraGENE Kit (OrageneTM DNA Collection Kit,
DNA Genotek Inc., Ottawa, ON, Canada) and the DNA was extracted following
the manufacturer’s’ protocol. All mothers signed informed consents approved by
the Human Research Ethics Committee from Biosciences Institute, University of
São Paulo (protocol no.: 184/2016).
Cell lines and maintenance of hiPSCs. hiPSCs were generated from CD71+ cells,
which were isolated from three pairs of DZ-D twins’ peripheral blood samples.
CD71-positive cells were sorted using magnetic labeled antibody (Miltenyi, Sup-
plementary Table 4) following the manufacturer’s instructions. All hiPSC lines
were tested for ZIKV infection by RT-qPCR using primers described in Supple-
mentary Table 2 and the results were negative. The reprogramming protocol was
performed with episomal vectors system (pCXLE-hOCT3/4-shP53-F, Addgene
plasmid 27077; pCXLE-hSK, Addgene plasmid 27078; pCXLE-hUL, Addgene
plasmid 27080; gift from Shinya Yamanaka), according to Okita et al.23, and using
the Amaxa human CD34+ cells Nucleofection Kit (Lonza), following the manu-
facturer’s recommendations.
Three days after nucleoporation, cells were seeded on irradiated murine
embryonic fibroblasts (Millipore, A24903) in embryonic stem cell medium
(Dulbecco's modified Eagle's medium (DMEM)/F12 supplemented with 2 mM
GlutaMAX-I, 0.1 mM non-essential amino acids, 100 μM 2-mercaptoethanol, 20%
of knockout serum replacement (all provided by Life Technologies), 10 ng/mL of
bFGF (Peprotech), 0.25 mM NaB, 0.5 mM VPA, 2 μM thiazovivin, 0.5 μM PD
0325901 and 2 μM SB 431542; all provided by Tocris Bioscience). The typical
hiPSC colonies were transferred to hESC-qualified Matrigel (Corning)-coated 60
mm petri dishes (Corning) and cultured in Essential 8 Medium (Gibco) with 100
μg/mL normocin (InvivoGen). All derived cell lines were checked for mycoplasma
contamination periodically.
Serological analysis. IgG antibodies analysis for ZIKV by ELISA was performed
in all three mothers’ serum samples using two distinct methods:
ZIKV ELISA method—first analysis: Specific IgG antibodies present in serum
samples were evaluated by ELISA according to a modified protocol based on
Euroimmun ZIKV ELISA24. ELISA plates (Corning Inc., New York, NY, USA)
were coated with a recombinant fragment of ZIKV NS1 (ΔNS1) (100 ng/well) or
with equimolar amount of a whole recombinant NS1 protein of DENV225 in a pH
7.2 phosphate-buffered saline (PBS) solution. The recombinant ZIKV proteins
were encoded by Escherichia coli BL21-Codon Plus DEIII strain (Stratagene, La
Jolla, CA, USA) transformed with pET28a plasmids (GenScript, USA) carrying
ZIKV ΔNS1 or NS1 sequences derived from the Brazilian strain (GenBank
reference number ALU33341). The ΔNS1 corresponded to the last 100 C-terminal
amino acids of the NS1 protein, which conferred higher specificity of the detected
anti-NS1 antibodies with regard to other flaviviruses. The soluble protein fractions
were obtained after hydrostatic pressure lysis (Artepeças, Brazil) in cells suspended
in lysis buffer (10 mM of Bis-Tris Propane, 150 mM of NaCl, 1 mM of
phenylmethylsulfonyl fluoride and pH 8.5). The recombinant proteins were
purified by affinity chromatography using a nickel-containing resin (Hiprep FF 5
mL, GE Healthcare Life Sciences) in a ÄKTA–AVANT device (GE Healthcare Life
Sciences). The column was washed with buffers containing 50 and 100 mM
imidazole and the bound proteins were eluted from the column with with 500 mM
imidazole. Samples containing the recombinant proteins were submitted to a
second chromatographic step based on size exclusion chromatography using a
Hiprep-SephacrylS-200HR 26/60 column (GE Healthcare Life Sciences). The
purified proteins were finally submitted to a final concentration step using nickel
affinity chromatography based on the same experimental conditions applied in the
first purification step. The purified samples were sorted in 15% polyacrylamide gels
and quantified by means of image software (Image Lab, Build 16, Version 4.1, Bio-
Rad Laboratories). The purified proteins were stored at −20 °C for subsequent uses.
Next, after pre-incubation, the diluted samples were incubated in blocked plates
(1.5 min, at room temperature) and the following steps were performed as
described elsewhere26. The optical density (OD) reading was measured at 492 nm
in a plate reader (Labsystems Multiskan, ThermoScientific, Waltham, MA, USA). A
signal-to-cut-off was calculated based on control samples and OD value ≥0.76 were
regarded as positive.
ZIKV ELISA method—second analysis: We used an ELISA Kit for detection of
IgG antibodies against ZIKV (Euroimmun, Lübeck, Germany) according to the
manufacturer’s instructions. In short, sera were diluted 1:100 in sample buffer and
incubated 37 °C for 60 min in a microplate well; a standard curve, positive and
negative controls, provided by the manufacturer, were used. The OD was measured
in a Multiskan EX (Thermo Scientific) and values ≥1.1 were regarded as positive.
Computed tomography scan. Two pairs of discordant twins (#10608 and #10763)
were submitted to computed tomography scan using 64 Channels Multislice
(Philips) with 120 kVp, 131 mA, portion thickness of 2.0, portion space of 1.0, 154
images in series, reconstruction diameter of 197 mm, and matrix of 512 × 512.
Neuroimages were analyzed using the ImageJ software.
Next-generation sequencing and variants filtering. WES was performed on
DNA samples from saliva from 8 CZS-affected twins plus 10 unrelated affected
babies. All sample libraries were prepared using Agilent’s SureSelect Human All
Exon V6 (Agilent Technologies, Santa Clara, CA, USA) and were sequenced on
Illumina HiSeq 2500 (Illumina, San Diego, CA, USA) for paired-end reads of
approximately 100 × 100 bp. An average on-target coverage of 57.6× was achieved.
Base coverage above 10 reads was 94.6%. Alignment of the sequences was per-
formed with the Burrows-Wheeler Aligner (BWA-MEM)27. The Picard (http://
broadinstitute.github.io/picard/) and Genome Analysis Toolkit (GATK-3.7)28 were
used for data processing and variant calling with Unified Genotyper tool. Anno-
tation of variants was performed with ANNOVAR29 and multiple public databases:
the 1000 Genomes Project National Institutes of Health, the 6500 Exome
Sequencing Project Washington University, and 609 elderly Brazilian controls from
our research center30. Our cohort sequencing data was compared with the cohort
of 609 Brazilian healthy individuals30. We did not identify pathogenic or probably
pathogenic statistically significant variants in genes related to Mendelian inherited
microcephaly or syndromes associated with microcephaly (Supplementary Data 2),
according to ACMG guidelines31. We did not find statistically significant variants
in genes involved with ZIKV replication in the host cell as potential susceptibility
factors for CZS32–34 (Supplementary Table 3). Statistical power was calculated
using the methods described elsewhere35 for case–control discrete trait with the
following parameters: number of controls (609); number of affected individuals
(18); expected risk allele frequency (0.05); expected disease prevalence (0.06);
expected relative risk per risk allele (7:1).
A second analysis consisted of evaluating potential damaging/deleterious
variants (missense and loss of function) with population frequency below 5%,
which were present in higher frequency in affected babies compared to our
Brazilian cohort (SABE609/ABraOM). Variants were also filtered for depth of
coverage above 10 reads and allelic balance between 0.3 and 0.7. We applied
distinct scores for genes with heterozygotes (score 1) and homozygotes (score 2)
variants, selecting those classified as probably deleterious/damaging in at least one
of five selected prediction tools (M-CAP, http://bejerano.stanford.edu/mcap/; SIFT,
http://sift.jcvi.org/; LRT36; MutationTaster, http://www.mutationtaster.org/; and
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DANN37. χ2 test followed by multiple tests correction (Bonferroni), comparing
affected twins with our control cohort was performed for all candidate genes.
MLPA assay. Total DNA was extracted from cultured cells using the NucleoSpin
Tissue Kit (Macherey-Nagel), followithe ng supplier’s instructions. MLPA analysis
was performed with subtelomeric kits (P036 and P070; MRC-Holland) to detect
chromosomal imbalances, as previously described38 (see Fig. 1d).
Differentiation of human hiPSCs into NPCs. hiPSCs were maintained for 3 days
with E8 medium (Life Technologies). On the fourth day, the medium was changed
to 0.5x NB medium (DMEM/F12 medium supplemented with 0.5x N2 and 0.5x
B27 (all provided by Life Technologies) added with 1 μM dorsomorphin (Tocris)
for 48 h. Further, the colonies were detached from the plate and cultured in sus-
pension as embryoid bodies (EBs) for 5 days in ultra-low attachment plates. The
EBs were plated on Matrigel-coated plates with NBF medium (DMEM/F12 med-
ium supplemented with 0.5x N2, 0.5x B27, 20 ng/mL fibroblast growth factor 2, 20
ng/mL epidermal growth factor, and 1% penicillin/streptomycin). The emerged
rosettes were manually picked, dissociated, and plated in a double-coated plate with
poly-ornithine (10 μg/mL, Sigma-Aldrich) and laminin (2.5 μg/L, Gibco). The NPC
population was expanded using NBF medium. hiPSCs and NPC validation was
performed by RT-qPCR and/or immunofluorescence and flow cytometry using
primers and antibodies, respectively, described in Supplementary Tables 2 and 4.
RNA-Seq assay. Total RNA from NPCs was extracted using the RNeasy Micro Kit
(Qiagen, 74004), treated with TURBO DNase (Ambion, AM2238) for 1 h at 37 °C,
and then re-purified with the Qiagen RNeasy Micro Kit. RNA samples were
quantified using the Qubit RNA HS Assay Kit (Thermo Fisher Scientific, Q32852);
purity was evaluated using NanoDrop ND-1000 Spectrophotometer (NanoDrop
Technologies) and the integrity was verified using the Agilent RNA 6000 Pico Kit
(Agilent Technologies, 5067-1513) in the 2100 Bioanalyzer Instrument (Agilent
Technologies). Stranded tagged cDNA libraries were prepared using the KAPA
Stranded mRNA-Seq Kit (Illumina, KK8421) and cluster generation was performed
using the Illumina HiSeq 4000 PE Cluster Kit (Illumina, PE-410-1001). Tagged
libraries were pooled and sequenced (300 cycles, paired-end sequencing) in the
Illumina HiSeq 4000 instrument using a HiSeq 4000 SBS Kit (Illumina, FC-410-
1003). Raw reads were preprocessed using the standard Illumina pipeline to seg-
regate multiplexed reads. Sequence quality was checked using the FastQC program
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc). Data were pre-
processed with the read trimming and cropping tool Trimmomatic v.0.3039.
Sequences were then aligned to the human reference genome GRCh38/hg38 using
STAR (v. 2.5.0a)40. Mapped reads were counted using the Ensembl GRCh38.83
transcriptome reference through the R software package GenomicRanges41, and
the statistical analyses of differential expression between samples were done using
EdgeR (v. 3.16.5)42. Networks of related enriched GO terms were created and
analyzed with Metascape43.
RNA-Seq validation by RT-qPCR. Total RNA from hiPSCs and NPCs was
extracted as described above. The reverse transcription (RT) reaction was per-
formed with 35 ng of each total RNA sample using the SuperScript IV First-Strand
Synthesis System (Life Technologies, cat. #18091050) and random hexamer pri-
mers in a 20 μL final volume. The obtained cDNAs were diluted 10 times in water
and quantitative PCR was performed using 2.5 μL of each diluted cDNA in a total
volume of 10 μL containing 1× LightCycler 480 SYBR Green I Master Mix (Roche
Diagnostics, cat. #04707516001) and 800 nM of each primer in a LightCycler 480
System (Roche Diagnostics). Each RT-qPCR was run in three technical replicates
and primers are shown in Supplementary Table 2. The TBP gene (NM_003194.4)
was used as the reference for internal normalization.
Neurosphere formation. Neuronal progenitor cells were cultured up to 80%
confluence and split with Accutase (Gibco, A1110501). Cells were counted and
reseeded at confluence of 8 × 105 cell/cm2 on poly-ornithine/laminin-coated 60
mm petri dishes. Six hours later the cells were detached after two washes with 1×
PBS followed by scraping and transferred to ultra-low attachment 6-well plates and
cultured with NBF medium at 37 °C, 5% CO2 (g), and 95 r.p.m. (0.1009 g) agitation
until the end of the experiment. The pictures were acquired using EVOS Cell
Imaging System (Thermo Fisher Scientific). A total of 10 pictures per group were
analyzed using the ImageJ software. This experiment was performed twice.
In situ immunofluorescence and flow cytometry staining. hiPSCs and NPCs
cultures were fixed with 4% PFA followed by permeabilization with 0.01% Triton
X-100 and then blocked with 5% bovine serum albumin (BSA) in 1× PBS (1 h).
After that, the cells were incubated overnight with primary antibodies (Supple-
mentary Table 4) at 4 °C and subsequently incubated with secondary fluorescent
antibodies for 1 h at room temperature. The final step was the DAPI (4',6-diami-
dino-2-phenylindole) staining for 2 min at room temperature. For ZIKV immu-
nofluorescence stain, cells were fixed with ice-cold acetone for 20 min, air dried,
blocked with 5% BSA, and stained for 1 h at 37 °C in a high humidity chamber with
primary antibody (Supplementary Table 4). Subsequently, secondary stain protocol
followed as described above. Confocal analysis was performed using Zeiss LSM
800. In order to analyze the MFI of ZIKV infection, approximately 50 cells per
group were measured for the respective fluorescent channel. This experiment was
performed in duplicate. Flow cytometry staining for neural progenitor marker
(Nestin; Musashi-1) were performed as follows. A total of 1 × 106 cells were fixed
for 20 min at room temperature using Fix and Perm Kit (Invitrogen) solution A.
The cells were washed with 1× PBS and permeabilized using the Fix and Perm Kit
solution B, incubated with primary antibody or isotype control antibody for 1 h on
ice. After washing with 1× PBS, cells were permeabilized and incubated with
secondary antibody for 1 h on ice. Flow cytometry data acquisition was performed
using FACS Aria (BD) collecting 10,000 events/run. Analysis was carried using the
FlowJo software.
Zika virus. ZIKVBR was a courtesy of Dr. Pedro Vasconcelos, InstitutoEvandro
Chagas, Brazil44. Viral stock was established after viral propagation for two serial
passages in VERO cells (ATCC® CCL-81™) in serum-free medium (VP SFM,
Thermo scientific).
Measurement of viral burden. Supernatants of cell culture were collected and
used for ZIKV titration by both, plaque assay, and absolute RT-qPCR. For plaque
assay, an amount of 6 × 104 VERO cells/well were seeded in 24-well plates 48 h
before the assay. Samples were serially diluted in DMEM culture medium from 10
−1 to 10−6, applied in duplicates of 200 µL to each well, and incubated for 30 min at
37 °C. After virus adsorption, wells were overlaid with culture medium containing
carboxymethyl cellulose (1%) and incubated at 37 °C. After 5 days, plates were
drained, washed with PBS, and stained with 0.1% naphthol blue-black, 1.6%
sodium acetate in 6% glacial acid acetic for 30 min. Plaque formation units were
visually determined in the most appropriate viral dilution and expressed as PFU/
mL. ZIKV RNA obtained from samples’ supernatants was extracted using Viral
RNA Mini Kit (Qiagen), according to the manufacturer’s protocol and viral RNA
copies were calculated by RT-qPCR.
For absolute RT-qPCR titration, a standard curve was generated with a double-
strand DNA fragment (KU365779.1:1179-1255) with sequence corresponding to a
region of Zika E protein (Supplementary Table 2). The fragment was quantified by
fluorometry (QuBit, Thermo Fisher) and the concentration required for a specific
number of target sequences was calculated. Six dilutions were performed in TE +
EGTA 1mM buffer, generating the standard dilutions containing 6 × 107, 6 × 106,
6 × 105, 6 × 104, 6 × 103, or 6 × 102 copies at each 3 µL. cDNA samples were
obtained after reverse transcription of Zika RNA using primers described
elsewhere45 and the SuperScript III Reverse Transcriptase Kit (Thermo Fisher).
Samples were amplified along with standard curve dilutions, in three replicates
each. Mean Cts were applied to standard curve equation to determine cDNA copy
numbers in each sample. The total Zika RNA copy numbers were calculated by
multiplication of the cDNA copy number by a conversion factor, which considered
all dilutions made during the RNA extraction to qPCR protocol.
Infection of the NPCs and neurospheres with ZIKVBR. NPCs were seeded into 6-
well or 24-well plates (Corning) and 2-well chamber slides (Nunc; Thermo Fisher
Scientific) to a confluence of 3 × 104 cells/cm2. NPCs (monolayer) as well as 3D
(neurospheres) were exposed to ZIKVBR (MOI: 0.01, 0.1, and Mock). Monolayer
cells were exposed to the virus for 1 h at 37 °C and 5% CO2 (g), washed with
medium 0.5x NB, and then maintained by up to 96 h (end point). The same
procedure was performed with the neurospheres, but with viral exposure for 2 h to
ensure complete sphere infection. mTOR inhibition and activation assay was
performed by infecting the NPCs (MOI 0.1) as described above, cells were kept in
culture with 200 nM of rapamycin (mTOR inhibitor) or 100 nM of bafilomycin
(mTOR activator) during the whole infection experiment. Then, ZIKVBR PFU and
copy numbers were analyzed from supernatant media, as previously described.
Cell counting and neurosphere diameter. Quantification of number of cells (for
each condition during 4 days) and alterations in neurosphere diameter over time
(24 and 96 hpi) were performed with NIH-ImageJ software. Data were determined
by ImageJ under original magnification x20 and reported as total number of cells
and neurosphere diameter. A total of 10 pictures per group were analyzed.
mTOR pathway multiplex assay. Cell culture samples were prepared for phos-
phoprotein and total protein assays using the premixed Magnetic MILLIPLEX
MAP 11-Plex Akt/mTOR Phosphoprotein Panel and the Magnetic MILLIPLEX
MAP 11-Plex Akt/mTOR total protein Pathway Signaling Kit (cat. # 48-611MAG;
48-612MAG, Millipore) according to the manufacturer’s instructions. In brief,
12.5 µg of protein of each sample was carried out using the manufacturer’s Assay
Buffer 2. Then, 25 μl of each standard and the samples were incubated with the
target capturing beads on a 96-well plate for 20 h at 4 °C, followed by a 1 h
incubation with the appropriate 1x MILLIPLEX MAP Detection Antibody at room
temperature. After the washing procedure, 1x MILLIPLEX MAP Streptavidin-PE
was added to each well and incubated for 30 min. Without discarding the strep-
tavidin-PE, we added amplification buffer and incubated it for 15 min at room
temperature. Samples were washed and re-suspended in assay buffer and the
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fluorescence was measured using a Luminex MAGPIX (Luminex, Austin, TX,
USA) for magnetic assays. Each sample was analyzed in triplicate.
Quantification and statistical analysis. Two-tailed unpaired t test was used for
pairwise comparison. One-way and two-way ANOVA was performed, followed by
post hoc pairwise comparison. Graphpad Prism software was used to perform all
statistical analysis (version 6.0). Quantification of data are represented as mean±
SEM and p value threshold was * 0.05, ** 0.01, and *** 0.001.
Data availability. The RNA-Seq data that support the findings of this study have
been deposited in the Gene Expression Omnibus NCBI repository under Accession
number GSE102128. All other data supporting the findings of this study are
available within the article and its Supplementary Information files, or are available
from the authors upon request. Due to privacy and consent restrictions, indivi-
dualized WES data files cannot be uploaded publicly to NCBI, but might be
available to researchers upon request and signature of a Data Use Agreement.
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